Selected research
Industry Research
Halofuginone Industry Research Report 2026
Market perspective
The global Halofuginone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Halofuginone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Halofuginone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Halofuginone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Halofuginone include Accel Pharmtech, Arctom, Biorbyt, ChemScene, ChemShuttle, Crysdot, Leancare, Molcan Corporation and Pharma Affiliates, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Halofuginone market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Halofuginone Market by Company
Accel Pharmtech
Arctom
Biorbyt
ChemScene
ChemShuttle
Crysdot
Leancare
Molcan Corporation
Pharma Affiliates
Dalian Meilun
Madision
Nanjing Romanme
Sunlidabio
Bidepharm
HanHong
Tautobiotech
Synchem
Shaghain Yuanye
Finetechchem
Yingnor
Acmechem
Halofuginone Segment by Type
95% Purity
97% Purity
98% Purity
99% Purity
Halofuginone Segment by Application
Aquaculture
Agriculture
Halofuginone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Halofuginone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Halofuginone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Halofuginone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Halofuginone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Halofuginone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Halofuginone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 95% Purity
- 97% Purity
- 98% Purity
- 99% Purity
Applications
- Aquaculture
- Agriculture
Companies covered
- Accel Pharmtech
- Arctom
- Biorbyt
- ChemScene
- ChemShuttle
- Crysdot
- Leancare
- Molcan Corporation
- Pharma Affiliates
- Dalian Meilun
- Madision
- Nanjing Romanme
- Sunlidabio
- Bidepharm
- HanHong
- Tautobiotech
- Synchem
- Shaghain Yuanye
- Finetechchem
- Yingnor
- Acmechem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Halofuginone Market Size (2021-2032)
- 2.2.2 Global Halofuginone Sales (2021-2032)
- 2.2.3 Global Halofuginone Market Average Price (2021-2032)
- 2.3 Halofuginone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 95% Purity
- 2.3.3 97% Purity
- 2.3.4 98% Purity
- 2.3.5 99% Purity
- 2.4 Halofuginone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Aquaculture
- 2.4.3 Agriculture
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Halofuginone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Halofuginone Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Halofuginone Revenue of Manufacturers (2021-2026)
- 3.4 Global Halofuginone Average Price by Manufacturers (2021-2026)
- 3.5 Global Halofuginone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Halofuginone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Halofuginone, Product Type & Application
- 3.8 Global Manufacturers of Halofuginone, Established Date
- 3.9 Global Halofuginone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accel Pharmtech
- 4.1.1 Accel Pharmtech Company Information
- 4.1.2 Accel Pharmtech Business Overview
- 4.1.3 Accel Pharmtech Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accel Pharmtech Halofuginone Product Portfolio
- 4.1.5 Accel Pharmtech Recent Developments
- 4.2 Arctom
- 4.2.1 Arctom Company Information
- 4.2.2 Arctom Business Overview
- 4.2.3 Arctom Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Arctom Halofuginone Product Portfolio
- 4.2.5 Arctom Recent Developments
- 4.3 Biorbyt
- 4.3.1 Biorbyt Company Information
- 4.3.2 Biorbyt Business Overview
- 4.3.3 Biorbyt Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Biorbyt Halofuginone Product Portfolio
- 4.3.5 Biorbyt Recent Developments
- 4.4 ChemScene
- 4.4.1 ChemScene Company Information
- 4.4.2 ChemScene Business Overview
- 4.4.3 ChemScene Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ChemScene Halofuginone Product Portfolio
- 4.4.5 ChemScene Recent Developments
- 4.5 ChemShuttle
- 4.5.1 ChemShuttle Company Information
- 4.5.2 ChemShuttle Business Overview
- 4.5.3 ChemShuttle Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 ChemShuttle Halofuginone Product Portfolio
- 4.5.5 ChemShuttle Recent Developments
- 4.6 Crysdot
- 4.6.1 Crysdot Company Information
- 4.6.2 Crysdot Business Overview
- 4.6.3 Crysdot Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Crysdot Halofuginone Product Portfolio
- 4.6.5 Crysdot Recent Developments
- 4.7 Leancare
- 4.7.1 Leancare Company Information
- 4.7.2 Leancare Business Overview
- 4.7.3 Leancare Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Leancare Halofuginone Product Portfolio
- 4.7.5 Leancare Recent Developments
- 4.8 Molcan Corporation
- 4.8.1 Molcan Corporation Company Information
- 4.8.2 Molcan Corporation Business Overview
- 4.8.3 Molcan Corporation Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Molcan Corporation Halofuginone Product Portfolio
- 4.8.5 Molcan Corporation Recent Developments
- 4.9 Pharma Affiliates
- 4.9.1 Pharma Affiliates Company Information
- 4.9.2 Pharma Affiliates Business Overview
- 4.9.3 Pharma Affiliates Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pharma Affiliates Halofuginone Product Portfolio
- 4.9.5 Pharma Affiliates Recent Developments
- 4.10 Dalian Meilun
- 4.10.1 Dalian Meilun Company Information
- 4.10.2 Dalian Meilun Business Overview
- 4.10.3 Dalian Meilun Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Dalian Meilun Halofuginone Product Portfolio
- 4.10.5 Dalian Meilun Recent Developments
- 4.11 Madision
- 4.11.1 Madision Company Information
- 4.11.2 Madision Business Overview
- 4.11.3 Madision Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Madision Halofuginone Product Portfolio
- 4.11.5 Madision Recent Developments
- 4.12 Nanjing Romanme
- 4.12.1 Nanjing Romanme Company Information
- 4.12.2 Nanjing Romanme Business Overview
- 4.12.3 Nanjing Romanme Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Nanjing Romanme Halofuginone Product Portfolio
- 4.12.5 Nanjing Romanme Recent Developments
- 4.13 Sunlidabio
- 4.13.1 Sunlidabio Company Information
- 4.13.2 Sunlidabio Business Overview
- 4.13.3 Sunlidabio Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Sunlidabio Halofuginone Product Portfolio
- 4.13.5 Sunlidabio Recent Developments
- 4.14 Bidepharm
- 4.14.1 Bidepharm Company Information
- 4.14.2 Bidepharm Business Overview
- 4.14.3 Bidepharm Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bidepharm Halofuginone Product Portfolio
- 4.14.5 Bidepharm Recent Developments
- 4.15 HanHong
- 4.15.1 HanHong Company Information
- 4.15.2 HanHong Business Overview
- 4.15.3 HanHong Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 HanHong Halofuginone Product Portfolio
- 4.15.5 HanHong Recent Developments
- 4.16 Tautobiotech
- 4.16.1 Tautobiotech Company Information
- 4.16.2 Tautobiotech Business Overview
- 4.16.3 Tautobiotech Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Tautobiotech Halofuginone Product Portfolio
- 4.16.5 Tautobiotech Recent Developments
- 4.17 Synchem
- 4.17.1 Synchem Company Information
- 4.17.2 Synchem Business Overview
- 4.17.3 Synchem Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Synchem Halofuginone Product Portfolio
- 4.17.5 Synchem Recent Developments
- 4.18 Shaghain Yuanye
- 4.18.1 Shaghain Yuanye Company Information
- 4.18.2 Shaghain Yuanye Business Overview
- 4.18.3 Shaghain Yuanye Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Shaghain Yuanye Halofuginone Product Portfolio
- 4.18.5 Shaghain Yuanye Recent Developments
- 4.19 Finetechchem
- 4.19.1 Finetechchem Company Information
- 4.19.2 Finetechchem Business Overview
- 4.19.3 Finetechchem Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Finetechchem Halofuginone Product Portfolio
- 4.19.5 Finetechchem Recent Developments
- 4.20 Yingnor
- 4.20.1 Yingnor Company Information
- 4.20.2 Yingnor Business Overview
- 4.20.3 Yingnor Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Yingnor Halofuginone Product Portfolio
- 4.20.5 Yingnor Recent Developments
- 4.21 Acmechem
- 4.21.1 Acmechem Company Information
- 4.21.2 Acmechem Business Overview
- 4.21.3 Acmechem Halofuginone Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Acmechem Halofuginone Product Portfolio
- 4.21.5 Acmechem Recent Developments
5 Global Halofuginone Market Scenario by Region
- 5.1 Global Halofuginone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Halofuginone Sales by Region: 2021-2032
- 5.2.1 Global Halofuginone Sales by Region: 2021-2026
- 5.2.2 Global Halofuginone Sales by Region: 2027-2032
- 5.3 Global Halofuginone Revenue by Region: 2021-2032
- 5.3.1 Global Halofuginone Revenue by Region: 2021-2026
- 5.3.2 Global Halofuginone Revenue by Region: 2027-2032
- 5.4 North America Halofuginone Market Facts & Figures by Country
- 5.4.1 North America Halofuginone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Halofuginone Sales by Country (2021-2032)
- 5.4.3 North America Halofuginone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Halofuginone Market Facts & Figures by Country
- 5.5.1 Europe Halofuginone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Halofuginone Sales by Country (2021-2032)
- 5.5.3 Europe Halofuginone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Halofuginone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Halofuginone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Halofuginone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Halofuginone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Halofuginone Market Facts & Figures by Country
- 5.7.1 South America Halofuginone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Halofuginone Sales by Country (2021-2032)
- 5.7.3 South America Halofuginone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Halofuginone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Halofuginone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Halofuginone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Halofuginone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Halofuginone Sales by Type (2021-2032)
- 6.1.1 Global Halofuginone Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Halofuginone Sales Market Share by Type (2021-2032)
- 6.2 Global Halofuginone Revenue by Type (2021-2032)
- 6.2.1 Global Halofuginone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Halofuginone Revenue Market Share by Type (2021-2032)
- 6.3 Global Halofuginone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Halofuginone Sales by Application (2021-2032)
- 7.1.1 Global Halofuginone Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Halofuginone Sales Market Share by Application (2021-2032)
- 7.2 Global Halofuginone Revenue by Application (2021-2032)
- 7.2.1 Global Halofuginone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Halofuginone Revenue Market Share by Application (2021-2032)
- 7.3 Global Halofuginone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Halofuginone Value Chain Analysis
- 8.1.1 Halofuginone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Halofuginone Production Mode & Process
- 8.2 Halofuginone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Halofuginone Distributors
- 8.2.3 Halofuginone Customers
9 Global Halofuginone Analyzing Market Dynamics
- 9.1 Halofuginone Industry Trends
- 9.2 Halofuginone Industry Drivers
- 9.3 Halofuginone Industry Opportunities and Challenges
- 9.4 Halofuginone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst